...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: RVXs up or down draft from ZENE???

Looks like we have 7 trials with multiple indications ending the first half of this year and 4 more the second half in ZENE. So we should expect some info which might effect ZENE assets and which should indirectly effect RVX. ....Comments appreciated!!!.....Or will our Pharma bed partners in ZENE refuse to publicly announce preliminary results,,will all be a big secret? Will RVX get funding from deals around indications?,,if so, might a full take out be best choice for a buyer of both these compnaies!

CEPC  -  Pll  -  Ends 1H 2024

Ovarian - Pl  - Ends 1H 2024

Nut Carcinoma - Pl/ll  -  1H 2024

PDAC Lymphoma - Pl/lb  -  1H 2024

TBNC,CRC   -   Pl   -   1H 2024

Ovarian PDAC  - Pll  - 1H 2024

CRPC, Breast,NSCLC  -  Pll -   1H 2024           

TNBC - Pl  -    1H 2024        

 

Share
New Message
Please login to post a reply